John has a deep passion for innovation that addresses challenging unmet needs of patients and physicians. With a background in physics and biomedical engineering, John has been deeply involved in multiple first-to-category product innovations throughout his career in clinical neurology, confocal imaging, medical imaging, remote patient monitoring and implantable medical devices. Over 30+ years of leadership experience from startups to leading US medtech companies such as GE Healthcare, Boston Scientific and Medtronic, uniquely positions John to lead this pioneering transformation of cancer care using smart bioelectronics and deep learning.
Chris Daft PhD
Chief Scientific Officer
Oxford-educated scientist whose areas of expertise include ultrasound imaging, electronics, semiconductors, medical devices, sensors, MEMS, signal processing and image processing.
Serial inventor who holds 22 U.S. Patents with several pending. Diverse industry experience with multi-nationals such as GE, Medtronic, Samsung and Siemens as well as several start-ups. Well published. Winner of grants from National Institute of Health and DARPA. IEEE Senior Member since 2004. Holds BA and MA in Physics and a Doctorate in Materials Science all from Oxford University in the UK.
Laurie brings an extensive background in healthcare innovation to the neuveo team. Her expertise in market and product development combined with her financial background has helped guide the neuveo story and articulate how our products benefit all stakeholders across the system, starting with patients. Laurie has senior level experience in health plans, hospital systems, digital health and wellness, software and medical device. Laurie is passionate about improving the care experience for cancer patients and providing advanced clinical decision support analytics for care teams.
Kevin comes to the neuveo team with a broad background in large pharmaceutical and medical device sales and marketing as well as extensive experience in start up medical device companies. With over 10 years experience in domestic and international healthcare leadership positions, Kevin believes the future of healthcare is personalized, provides value to all stakeholders, and driven by big data and predictive analytics. Treatment should move from the “find and fix” mentality to “predict and prevent.” Kevin is currently named on 4 patents, with 3 in ultrasound based technologies.